Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.330
+0.020 (1.53%)
At close: May 1, 2026, 4:00 PM EDT
1.300
-0.030 (-2.26%)
After-hours: May 1, 2026, 7:59 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $21.68 million as of May 1, 2026. Its market cap has decreased by -50.83% in one year.
Market Cap
21.68M
Enterprise Value
22.40M
1-Year Change
-50.83%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $21.68M, a decrease of -97.47%. That is a compound annual growth rate of -40.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 21.68M | -88.38% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 22.98M |
| Serina Therapeutics | 22.20M |
| OSR Holdings | 21.82M |
| VYNE Therapeutics | 21.46M |
| Allarity Therapeutics | 21.20M |
| Exicure | 20.46M |
| Cadrenal Therapeutics | 20.05M |
| CEL-SCI | 19.83M |